ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2497

Evidence Of a Microbial Signature In The Intestinal Microbiome In Ankylosing Spondylitis

Mary-Ellen Costello1, Francesco Ciccia2, Brooke Gardiner3, Mhairi Marshall3, Dana Willner4, Tony Kenna3, Giovanni Triolo2 and Matthew A. Brown3, 1Human Genetics Group, University of Queensland Diamantina Institute, Brisbane, Australia, 2Rheumatology Unit, University of Palermo, Palermo, Italy, 3University of Queensland Diamantina Institute, Brisbane, Australia, 4Australian Centre for Ecogenomics, School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS) and microbiome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis: Pathogenesis, Etiology, Animal Models II

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Ankylosing spondylitis (AS) occurs in genetically predisposed individuals exposed to an unknown but likely ubiquitous environmental trigger.  In both AS and Crohn’s disease (CD) interplay between host genetic factors and largely undefined environmental factors, most likely involving the gut microbiome, are thought to drive the disease. To date, no comprehensive characterization of intestinal microbiota in AS patients has been performed. Our objective was to characterize the intestinal microbiome of newly diagnosed TNF-antagonist naïve AS cases using next generation sequencing and to determine if the AS gut carries a distinct microbial signature. To explore the effect of host genotype on microbiome composition we also characterized the intestinal microbiome in stools of mice with knockouts of two major AS-susceptibility genes, ERAP and IL23R, in comparison with wild-type controls.  

Methods:

Terminal ileal (TI) biopsies from patients with AS, CD and healthy controls (HC) and mouse faecal samples were profiled using culture-independent high-throughput next generation sequencing of the 16S rRNA gene on an Illumina MiSeq.

Results:

Our results show the TI microbial communities of AS patients differ significantly and are more diverse than the intestinal microbial communities from those with CD and HC. The AS microbial community is characterized by higher abundance of five families of bacteria, Lachnospiraceae, Veillonellaceae, Prevotellaceae, Ruminococcusaceae and Porphyromonadaceae. Increased abundances of the families Lachnospiraceae and Prevotellaceae have been strongly associated with colitis and CD. TI microbial composition was found to correlate with disease status (P=<0.001) and greater differences were observed between disease groups than within disease groups.  In mice, absence of either ERAP or IL23R alone was sufficient to significantly alter the microbiome. Absence of ERAP and IL23R caused an increase a member of the Rikenellaceae family bacteria, Rikenella Alistipes spp., compared to wild type controls (P=0.001). Rikenella Alistipes spp. is an indicator species found to be driving the AS TI microbiome signature (P=0.001). In the IL23R –/– mice, there was an increase in the genus Parabacteroides (P=0.023) (Porphyromonadaceae family).  No clustering of mouse stool microbiome was noted in relationship to the cage mice were raised in, confirming that these differences are driven by the mouse genotype and not local environmental effects.  In our AS cohort we also see an increase the same genus of bacteria.  

Conclusion:

AS case microbiomes are different from those of CD and HC, and knockout mouse studies show that AS-associated genes shape the intestinal microbiome.  This is consistent with models for AS in which genetic effects lead to changes in the gut microbiome which in turn cause immunological effects which lead to AS.


Disclosure:

M. E. Costello,
None;

F. Ciccia,
None;

B. Gardiner,
None;

M. Marshall,
None;

D. Willner,
None;

T. Kenna,
None;

G. Triolo,
None;

M. A. Brown,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evidence-of-a-microbial-signature-in-the-intestinal-microbiome-in-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology